Government Purchases More COVID Treatments from Lilly
Indianapolis-based Eli Lilly and Co. (NYSE: LLY) says the U.S. government has made another purchase of 614,000 doses of the combination bamlanivimab and etesevimab antibody therapy for COVID-19. As pa... Read More
